Impact of monoclonal antibody treatments on Hidradenitis Suppurativa related emergency department visits: a retrospective cohort analysis

Arch Dermatol Res. 2024 Nov 1;316(10):730. doi: 10.1007/s00403-024-03479-y.

Authors

Henry O Herrera¹, Christopher R Cullison², Kaden M Thomas³, Jeremy S Bordeaux²

Affiliations

¹ Department of Dermatology, Case Western Reserve University, Cleveland, OH, USA. hoh2@case.edu.
² Department of Dermatology, University Hospitals Cleveland Medical Center, Case Western Reserve University, 9501 Euclid Ave, Cleveland, OH, 44106, USA.
³ Department of Dermatology, Case Western Reserve University, Cleveland, OH, USA.

PMID: 39485548
DOI: 10.1007/s00403-024-03479-y

No abstract available

Keywords: Adalimumab; Emergency visits; Hidradenitis Suppurativa; Infliximab; Secukinumab.